EUVIMEDEUVIMED entdecken
Crossref

Patient views regarding cannabis use in chronic kidney disease and kidney failure: a survey study

David Collister, Gwen Herrington, Lucy Delgado, Reid Whitlock iD, Karthik Tennankore, Navdeep Tangri, Remi Goupil, Annie-Claire Nadeau-Fredette, Sara N Davison, Ron Wald, Michael Walsh

Nephrology Dialysis Transplantation · 31.03.2023 · 38 (4) · 922-931

DOI: 10.1093/ndt/gfac226 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nephrology Dialysis Transplantation, online erschienen am 26.07.2022. Verfasst von David Collister und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, Department of Medicine, University of Alberta, Edmonton, AB, Canada. Hauptthemen laut MEDLINE: Cannabis, Restless Legs Syndrome, Renal Insufficiency, Chronic. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: Michael G. DeGroote Centre for Medicinal Cannabis Research at McMaster University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cannabis is frequently used recreationally and medicinally, including for symptom management in patients with kidney disease.

Methods

We elicited the views of Canadian adults with kidney disease regarding their cannabis use. Participants were asked whether they would try cannabis for anxiety, depression, restless legs, itchiness, fatigue, chronic pain, decreased appetite, nausea/vomiting, sleep, cramps and other symptoms. The degree to which respondents considered cannabis for each symptom was assessed with a modified Likert scale ranging from 1 to 5 (1, definitely would not; 5, definitely would). Multilevel multivariable linear regression was used to identify respondent characteristics associated with considering cannabis for symptom control.

Results

Of 320 respondents, 290 (90.6%) were from in-person recruitment (27.3% response rate) and 30 (9.4%) responses were from online recruitment. A total of 160/320 respondents (50.2%) had previously used cannabis, including smoking [140 (87.5%)], oils [69 (43.1%)] and edibles [92 (57.5%)]. The most common reasons for previous cannabis use were recreation [84/160 (52.5%)], pain alleviation [63/160 (39.4%)] and sleep enhancement [56/160 (35.0%)]. Only 33.8% of previous cannabis users thought their physicians were aware of their cannabis use. More than 50% of respondents probably would or definitely would try cannabis for symptom control for all 10 symptoms. Characteristics independently associated with interest in trying cannabis for symptom control included symptom type (pain, sleep, restless legs), online respondent {β = 0.7 [95% confidence interval (CI) 0.1–1.4]} and previous cannabis use [β = 1.2 (95% CI 0.9–1.5)].

Conclusions

Many patients with kidney disease use cannabis and there is interest in trying cannabis for symptom control.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CannabisRestless Legs SyndromeRenal Insufficiency, ChronicAdultHumansCanadaSurveys and QuestionnairesPain

Stichwörter der Autor:innen

cannabiskidney diseasesurveysymptoms

Autor:innen und Institutionen

  • Division of Nephrology, Department of Medicine, University of Alberta, Edmonton, AB, Canada.
  • Department of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada.
  • Department of Anesthesia, McMaster University, Hamilton, ON, Canada.
  • Population Health Research Institute, Hamilton, ON, Canada, Chronic Disease Innovation Centre, Winnipeg, MB, Canada.
  • Can-SOLVE CKD, University of British Columbia, Vancouver, BC, Canada.
  • Chronic Disease Innovation Centre, Winnipeg, MB, Canada.

ORCID-Profile: Reid Whitlock

Förderung

  • Michael G. DeGroote Centre for Medicinal Cannabis Research at McMaster University

Zitieren

APA

Collister, D., Herrington, G., Delgado, L., Whitlock, R., Tennankore, K., Tangri, N., Goupil, R., Nadeau-Fredette, A. C., Davison, S. N., Wald, R., & Walsh, M. (2023). Patient views regarding cannabis use in chronic kidney disease and kidney failure: a survey study. Nephrology Dialysis Transplantation, 38(4), 922-931. https://doi.org/10.1093/ndt/gfac226

Vancouver

Collister D, Herrington G, Delgado L, Whitlock R, Tennankore K, Tangri N, et al. Patient views regarding cannabis use in chronic kidney disease and kidney failure: a survey study. Nephrology Dialysis Transplantation. 2023;38(4):922-931. doi:10.1093/ndt/gfac226

BibTeX
@article{Collister2023,
  author = {Collister, David and Herrington, Gwen and Delgado, Lucy and Whitlock, Reid and Tennankore, Karthik and Tangri, Navdeep and Goupil, Remi and Nadeau-Fredette, Annie-Claire and Davison, Sara N and Wald, Ron and Walsh, Michael},
  title = {Patient views regarding cannabis use in chronic kidney disease and kidney failure: a survey study},
  journal = {Nephrology Dialysis Transplantation},
  year = {2023},
  volume = {38},
  number = {4},
  pages = {922--931},
  doi = {10.1093/ndt/gfac226}
}
Kostenlos starten →